RESTON, Va., June 21, 2017 /PRNewswire/ -- Leidos (NYSE:
LDOS), a FORTUNE 500® science and technology company,
was awarded a prime position on the Strategic Partners Acquisition
Readiness Contract (SPARC) vehicle by the Centers for Medicare
& Medicaid Services (CMS). The multiple-award
indefinite-delivery/indefinite-quantity (IDIQ) contract has a
five-year period of performance and a total contract value of
$25 billion for all awardees, if all
options are exercised. Leidos is one of 62 contractors eligible to
compete for task orders under the contract. Work will be performed
primarily in Windsor Mill, Md.
SPARC provides strategic, technical, and program management
guidance and support services to facilitate the modernization of
business processes and supporting systems. Under the contract,
Leidos will apply technical expertise in various professional
services including design, development, requirement, testing,
security control assessment, and independent verification and
validation.
"We have extensive experience in providing innovative technology
services and we look forward to continuing a tradition of
excellence through the SPARC vehicle," said Leidos Health Group
President, Jon Scholl.
About Leidos
Leidos is a FORTUNE 500®
science and technology solutions and services leader working to
solve the world's toughest challenges in the defense, intelligence,
homeland security, civil, and health markets. The company's 32,000
employees support vital missions for government and commercial
customers. Headquartered in Reston,
Virginia, Leidos reported annual revenues of approximately
$7.04 billion for the fiscal year
ended December 30, 2016. For more
information, visit www.Leidos.com.
Statements in this announcement, other than historical data
and information, constitute forward-looking statements that involve
risks and uncertainties. A number of factors could cause our actual
results, performance, achievements, or industry results to be very
different from the results, performance, or achievements expressed
or implied by such forward-looking statements. Some of these
factors include, but are not limited to, the risk factors set forth
in the company's Annual Report on Form 10-K for the period ended
December 30, 2016, and other such
filings that Leidos makes with the SEC from time to time. Due to
such uncertainties and risks, readers are cautioned not to place
undue reliance on such forward-looking statements, which speak only
as of the date hereof.
Contact:
|
Melissa
Koskovich
|
Jennifer
Moffett
|
|
(571)
526-6850
|
(571)
526-6852
|
|
Koskovichm@Leidos.com
|
Jennifer.a.moffett@leidos.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/centers-for-medicare--medicaid-services-awards-leidos-spot-on-strategic-partners-acquisition-readiness-contract-300477846.html
SOURCE Leidos